SCHEMBL14720589

SCHEMBL14720589

CC(C)(C)OC(=O)N1CCC(=Cc2ccc(CBr)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.43
▸ SRD5A1 P18405 1/20 0.42
▸ ESR2 Q92731 1/20 0.41
▸ SRD5A2 P31213 1/20 0.40
▸ NR1H2 P55055 1/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ HDAC2 Q92769 1/20 0.39
▸ OGA O60502 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GPR119 Q8TDV5 3/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ USP2 O75604 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ CHRM1 P11229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720749 0.86 SRD5A1 (0.58) GRM5SRD5A1ESR2SRD5A2NR1H2
SCHEMBL18992022 0.86 OGA (0.45) GRM5SRD5A1ESR2SRD5A2NR1H2
SCHEMBL14720896 0.86 GRM5 (0.46) GRM5ESR2NR1H2MEN1KMT2A
SCHEMBL1870570 0.83 NR1H2 (0.54) GRM5ESR2NR1H2MEN1KMT2A
SCHEMBL4635083 0.83 GRM5 (0.46) GRM5ESR2NR1H2MEN1KMT2A
SCHEMBL5497099 0.83 MEN1 (0.55) GRM5ESR2NR1H2MEN1KMT2A
SCHEMBL1473227 0.83 GPR119 (0.51) GRM5SRD5A1ESR2SRD5A2NR1H2
SCHEMBL15699606 0.82 ALDH1A1 (0.54) GRM5OGASMN1; SMN2GPR119HTT
SCHEMBL20304919 0.82 SRD5A2 (0.55) GRM5ESR2SRD5A2NR1H2MEN1
SCHEMBL16113569 0.81 MAPT (0.54) GRM5ESR2SRD5A2NR1H2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 — — WO disclosed
Send feedback